MGMT and glioblastoma: Indeed, [18F]FDOPA PET-guided dose-escalated radiation therapy significantly improved the overall survival in the subgroup of O6-methylguanine-DNA methyltransferase (MGMT) methylated glioblastoma patients and the progression-free survival in MGMT unmethylated glioblastoma patients [38].